Author:
Hanna Daire,Chopra Neha,Hochhauser Daniel,Khan Khurum
Reference101 articles.
1. Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study;Andre;J. Clin. Oncol.,2020
2. New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors;Liu;Curr Treat Options Oncol.,2016
3. PARP inhibitors: Synthetic lethality in the clinic;Lord;Science,2017
4. Anon, XXXXb. Phase II Study of Niraparib and TSR-042 in Patients with Germline or Somatic BRCA1/2 and PALB2-related Pancreatic Cancer – Mayo Clinic. 〈https://www.mayo.edu/research/clinical-trials/cls-20491028〉.
5. Anon, XXXXc. Study of BGB-290 or Placebo in Patients With Advanced or Inoperable Gastric Cancer | Smart Patients. 〈https://www.smartpatients.com/trials/NCT03427814〉.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献